Background {#s1}
==========

Produced by bone marrow megakaryocytes, platelets are small anucleate elements of the blood that play a pivotal role in hemostasis. They are involved in fibrinolysis and repair of the vessel wall, while circulating in the blood as sentinels of vascular integrity. Platelets lack genomic DNA but retain the ability for protein synthesis from cytoplasmic mRNA [@pone.0081809-Kieffer1]. Platelet mRNA was first isolated and converted to a cDNA library more than two decades ago [@pone.0081809-Wicki1]. In recent years, several studies utilizing genome-wide techniques for gene expression profiling, such as microarrays and Serial Analysis of Gene Expression (SAGE) in concert with computer-assisted bioinformatics, have reported that thousands of gene transcripts are present in human platelets [@pone.0081809-Bugert1]--[@pone.0081809-Rox1]. While microarrays and SAGE have made significant contributions to the characterization of the platelet transcriptome, they also have serious limitations. Hybridization-based approaches rely on probe-target binding of selected sequences and do not detect novel transcripts or unknown genes. In contrast, SAGE uses sequence tags from individual mRNAs and has an advantage over microarrays by detecting unknown genes but does not provide information on splice isoforms and is biased toward short tags, which cannot be uniquely mapped to the human genome [@pone.0081809-Wang1]. Recently, mass sequencing of transcripts (RNA-Seq) by next generation sequencing (NGS) technologies has emerged as a powerful approach for quantitative transcript discovery [@pone.0081809-Heap1]--[@pone.0081809-Sultan1]. RNA-Seq has clear advantages over other approaches [@pone.0081809-Wilhelm1] and shows higher levels of reproducibility for both technical and biological replicates [@pone.0081809-Costa1]. Two recently published studies used NGS technology to characterize the platelet transcriptome [@pone.0081809-Bray1]--[@pone.0081809-Rowley1]. One of these used cDNA from poly(dT) isolated mRNA and the other cDNA from ribosomal RNA-depleted total RNA. Both studies used relatively short reads (≤50 base pairs) for alignment to the human genome. In this context, we now report results from both polyA+ mRNA and rRNA-depleted total RNA approaches utilizing 100 bp long sequencing reads for investigating the transcriptional profile of unstimulated human platelets ([Fig. 1](#pone-0081809-g001){ref-type="fig"}). We have also for the first time applied a *de novo* assembly of platelet transcripts to confirm the reference-guided alignments. We believe that our data may provide important clues for understanding the elusive platelet transcriptome and its role in the coagulation system and hemostasis.

![Schematic presentation of experimental plan used in this study.\
Samples from 4 platelet donors were investigated. One sample (S0) was used for isolation of polyA+ transcripts. The 3 other samples (S1, S2, and S3) were used for analysis of total RNA after depletion of ribosomal RNA (rRNA).](pone.0081809.g001){#pone-0081809-g001}

Results {#s2}
=======

Mapping of polyA+ mRNA (Sample S0) {#s2a}
----------------------------------

We tried three mapping strategies for polyA+ mRNA ([Fig. 2](#pone-0081809-g002){ref-type="fig"}).

![Mapping strategies and abundance estimates.\
i) Alignment of reads (short red lines) to the human reference genome hg19 (thick blue line) using the TopHat program that aligns RNA-Seq reads to the genome while also attending to splice junction reads. Abundance estimates obtained by counting the number of reads that map within the coordinates defining the corresponding gene with RefSeq annotations; ii) Alignment of reads (short red lines) to human reference (RefSeq) mRNA (thick blue line with polyA tail) using the bwa software for abundance estimates; iii) Alignment of reads (short red lines) to a *de novo* assembled transcript reported by Trinity (thick red line with polyA tail and green SMARTer IIA oligonucleotide as 5′-leader sequence) using Blat for identification and RSEM for abundance estimates.](pone.0081809.g002){#pone-0081809-g002}

First, the 58,155,680 cleaned sequenced single-end reads with no strand-specificity were mapped to the human reference genome (GRCh37/hg19) using TopHat software (<http://tophat.cbcb.umd.edu/>) in order to identify exon-exon splice junctions ([Fig. 2](#pone-0081809-g002){ref-type="fig"} i). This resulted in 35,322,009 (60.7%) of uniquely mapped ∼100 bp long single-end reads. The aligned sequencing reads and the Homo_sapiens.GRCh37.71.gtf features were used to estimate the coverage of known genes and transcripts with the aid of bedtools-2.17.0 (<http://code.google.com/p/bedtools/>). A strong bias towards the 3′-UTR end of transcripts was clearly evident, which can be expected due to the library construction involving oligo-dT primed cDNA in the library preparation procedure ([Fig. 3](#pone-0081809-g003){ref-type="fig"}). The uniquely mapped read localizations on the different chromosomes are shown in [Table 1](#pone-0081809-t001){ref-type="table"}. Top 30 loci are shown in [Table 2](#pone-0081809-t002){ref-type="table"}. The HTSeq counts are shown in Table S1 in [File S1](#pone.0081809.s001){ref-type="supplementary-material"}.

![Read start position density on *ACTB* mRNA.\
The horizontal axis shows the distance in nucleotides (bp) from the 5′-end of *ACTB* mRNA, and the vertical axis shows the natural logarithm of the number of uniquely mapped reads. The fitted red line calculated over the transcript body ignoring both ends corresponds to exponential decay of approximately 50% per 250 bp upstreams fom the polyA-site in the 3′-UTR. Correlation coefficient: 0.93, Slope: 0.0027638, Std error: 0.0002751, t value: -10.05, p-value: 4.70e-08 \*\*\*. (Statistics and graph generated by the R-program).](pone.0081809.g003){#pone-0081809-g003}

10.1371/journal.pone.0081809.t001

###### Distribution of mapped reads for samples S0, S1, S2 and S3.

![](pone.0081809.t001){#pone-0081809-t001-1}

  Transcript info    No. Mapped reads per sample                                   
  ----------------- ----------------------------- ---------- ---------- ---------- ----------
  1                           249250621            1417879    5604828    6082062    5836619
  2                           243199373             839205    4828700    4942088    5293788
  3                           198022430             376751    4053306    3561770    5497609
  4                           191154276            1574321    5304616    5313861    8582878
  5                           180915260             987877    2476361    2751025    2864982
  6                           171115067             510420    3116547    3325548    3279675
  7                           159138663             534153    2881230    2900407    3260889
  8                           146364022             202649    1788536    1718024    1966160
  9                           141213431             182805    2898002    2193803    4043810
  10                          135534747             228845    2687946    2569453    2952239
  11                          135006516             915079    2259841    1890737    2206632
  12                          133851895             396073    2337950    2332903    2698125
  13                          115169878             733311    1026903    1066507    1135743
  14                          107349540             165457    6691970    4061007    12098431
  15                          102531392            1039909    5280432    5780695    5035062
  16                          90354753              168779     946256     807193     892257
  17                          81195210              440380    1934478    1881603    2076841
  18                          78077248              92840     1184820    1263978    1233671
  19                          59128983              257403     860224     632489     900418
  20                          63025520              425316    1327116    1295269    1404632
  21                          48129895              92487      741307     599255     624149
  22                          51304566              148511     750870     567420     726189
  X                           155270560            1153342    7951615    6776104    6929134
  Y                           59373566              21311      51658       4949      50979
  MT                            16569              22416906   6781716    9016861    7198049
  Sum:                        35322009             76000000   73335011   88788961  

10.1371/journal.pone.0081809.t002

###### TopHat alignment of PolyA + mRNA to genome.

![](pone.0081809.t002){#pone-0081809-t002-2}

  Ensembl id.         Gene             Locus            NRC[\*](#nt101){ref-type="table-fn"}   Rank
  ----------------- --------- ------------------------ -------------------------------------- ------
  ENSG00000210082    MT-RNR2       MT:1671--3229                      10000000                  MT
  ENSG00000211459    MT-RNR1        MT:648--1601                      5000000                   MT
  ENSG00000205542    TMSB4X     X:12993226--12995346                  1000000                   1
  ENSG00000166710      B2M     15:45003674--45011075                   862880                   2
  ENSG00000198888    MT-ND1        MT:3306--4262                       833782                   MT
  ENSG00000163736     PPBP      4:74852754--74853914                   555955                   3
  ENSG00000198712    MT-CO2        MT:7585--8269                       534277                   MT
  ENSG00000163737      PF4      4:74844540--74848796                   437842                   4
  ENSG00000198763    MT-ND2        MT:4469--5511                       407889                   MT
  ENSG00000198886    MT-ND4       MT:10469--12137                      355599                   MT
  ENSG00000198899    MT-ATP6       MT:8365--9990                       303773                   MT
  ENSG00000198938    MT-CO3        MT:8365--9990                       303743                   MT
  ENSG00000198786    MT-ND5       MT:12336--14148                      287825                   MT
  ENSG00000198804    MT-CO1        MT:5903--7445                       282378                   MT
  ENSG00000198727    MT-CYB       MT:14746--15887                      217548                   MT
  ENSG00000187514     PTMA     2:232571605--232578251                  210648                   5
  ENSG00000161570     CCL5     17:34195970--34212867                   185274                   6
  ENSG00000228474     OST4      2:27265231--27294641                   180079                   7
  ENSG00000198695    MT-ND6       MT:14148--14673                      148341                   MT
  ENSG00000198840    MT-ND3       MT:10058--10404                      105928                   MT
  ENSG00000212907    MT-ND4L      MT:10469--12137                      98894                    MT
  ENSG00000075624     ACTB       7:5566781--5603415                    91079                    8
  ENSG00000127920     GNG11     7:93220884--93567791                   85225                    9
  ENSG00000204592     HLA-E     6:30457244--30461982                   82263                    10
  ENSG00000087086      FTL     19:49468558--49470135                   81047                    11
  ENSG00000158710    TAGLN2    1:159887897--159895522                  77614                    12
  ENSG00000120885      CLU      8:27454434--27472548                   72310                    13
  ENSG00000168497     SDPR     2:192699027--193060435                  71863                    14
  ENSG00000150681     RGS18    1:192127586--192154945                  65222                    15
  ENSG00000163041     H3F3A    1:226249552--226259702                  63326                    16

\*NRC =  Normalized Read Counts calculated from transcript length (x) as NRC =  read_count\*(1+e-0.0027638x).

Second, to check the quality of the TopHat alignments the reads were also mapped against RefSeq mRNAs ([Fig. 2](#pone-0081809-g002){ref-type="fig"} ii) using bwa (<http://bio-bwa.sourceforge.net/>) and samtools (<http://samtools.sourceforge.net/>) giving similar results (data not shown). PolyA-sites and the expression level of individual transcripts were visualized by plotting log coverage against the distance from the 5′-end of the RefSeq mRNA sequences ([Fig. 4](#pone-0081809-g004){ref-type="fig"}). Additional data is shown in Table S2 in [File S1](#pone.0081809.s001){ref-type="supplementary-material"}.

![Mapping of S0 (poly(dT) selected transcripts) against RefSeq mRNA.\
The horizontal axis shows the distance in nucleotides from the 5′-end of the transcript (bin length  = 100 bp), and the vertical logarithmic axis shows the sum of uniquely mapped reads to each position of the bin. The slope of the dotted line corresponds to the exponential decay function derived in [Fig. 3](#pone-0081809-g003){ref-type="fig"}. The sudden "drops" correspond to polyA-sites. As seen in the figure NM_002704 (*PPBP*) has two polyA-sites which correspond to the known polyA-sites at positions 708 and 1307, respectively. The abundance of the longer *PPBP* transcript appears to be hundred-fold lower than that of the shorter transcript.](pone.0081809.g004){#pone-0081809-g004}

Finally, a detailed analysis of transcripts and assignment of mRNA isoforms was performed by *de novo* assembly of transcripts using Trinity RNA-Seq software from (<http://trinityrnaseq.sourceforge.net/>) followed by quantification of transcripts with RSEM (RNA-Seq by Expectation-Maximization) ([Fig. 2](#pone-0081809-g002){ref-type="fig"} iii). Identification of the *de novo* assembled transcripts was achieved by Blat and BLAST searches using the UCSC Browser and the NCBI Genome databases, respectively. [Table 3a](#pone-0081809-t003){ref-type="table"} shows the Top 25 out of 9077 reported *de novo* assembled polyA+ genomic transcripts with identification to locus; excluding the mitochondrial genome for clarity. Full-length transcripts could be identified by the presence of a SMARTer IIA 5′-leader sequence and a 3′-end polyA tail ([Fig 5](#pone-0081809-g005){ref-type="fig"}). The magnitude of expression of *de novo* assembled polyA+ transcripts correlated well (Spearman\'s rho  = 0.83) with the length normalized coverage by TopHat alignment of polyA+ cDNA reads to the human genome (compare [Tables 2](#pone-0081809-t002){ref-type="table"} and [3a](#pone-0081809-t003){ref-type="table"}).

![Snapshot of UCSC Browser Blat alignment of *de novo* assembled transcript variant comp1_c0_seq1 mapping to TMSB4X.\
The 5′-leader sequence matches the SMARTer IIA oligonucleotide. The Trinity *de novo* assembled nucleotide sequence is identical to the GRCh37/hg19 reference. Part of the polyA tail is also included. Splice junctions are marked in turquoise.](pone.0081809.g005){#pone-0081809-g005}

10.1371/journal.pone.0081809.t003

###### de novo assembly of platelet transcripts.

![](pone.0081809.t003){#pone-0081809-t003-3}

  Table 3a. Trinity/RSEM    Table 3b. Trinity/RSEM                                                               
  ------------------------ ------------------------ ------ ------- --------- ------- ----------- ------ -------- --------
  1                                 TMSB4X           673    67846   1399035   ncrna    7SLRNA     349    295364   120832
  2                                  B2M             992    28110   827815      1      TMSB4X     646    145005   15806
  3                                  PPBP            1789   10067   524473      2        B2M      990    64093     8783
  4                                  PF4             1035   13004   398344      3       PPBP      2296   22402    12048
  5                                  OST4            470    19998   291396    ncrna    7SK-RNA    330     9981     2495
  6                                  CCL5            777    6289    148021    ncrna   LSU-rRNA    1032    8029     6510
  7                                  FTH1            961    5068    144939      4       FTH1      955     8008     1385
  8                                 SERF2            598    6988    129001    ncrna    RNA45S5    307     6586     4582
  9                                  PTMA            1036   4101    125730      5        PF4      1201    6367     3351
  10                                H3F3B            1087   3849    123435      6      SMARCA5    510     5991     1417
  11                               SH3BGRL3          781    4037     95446      7       OST4      492     5765     1800
  12                                 ACTB            974    3058     88556      8       PF4V1     530     3609     505
  13                                 FTL             914    3053     83361      9      C21orf7    1527    3207     912
  14                                TAGLN2           1414   1866     76941     10       ACTB      1680    2991     637
  15                                GNG11            876    2804     73644     11       MYL6      700     2705     678
  16                                 PTMA            320    6581     62019     12       CCL5      777     2569     370
  17                                RGS18            4238    485     61271     13       GNG11     1004    2493     1019
  18                               C21orf7           1518   1341     59276     14      HSMAR1     1756    2456     344
  19                                 SDPR            2554    774     58065     15       RGS18     4443    2432     160
  20                                TUBB1            3109    612     56270     16       H3F3A     588     2370     736
  21                                 MYL6            696    2509     53370     17     HIST1H2AC   1744    2280     424
  22                                 CLU             1769    939     48350     18      MYL12A     1316    2278     552
  23                                HLA-E            1492   1025     44539     19      EFCAB13    608     2234     704
  24                                 GPX1            907    1301     35274     20       MORC3     714     2225     834
  25                                RGS10            1001   1136     33743     21       PTMA      1232    2179     667

Fragments Per Kilobase of transcript per Million mapped reads.

\*NRC =  Normalized Read Count calculated from transcript length (x) as NRC =  read_count\*(1+e-0.0027638x).

Ranking of protein coding transcripts only.

Mapping of rRNA-depleted total RNA (Samples S1, S2 and S3) {#s2b}
----------------------------------------------------------

The three barcoded rRNA-depleted total RNA libraries (S1,S2 and S3) resulted in 153 million pass filter strand-specific read pairs (QC data in Fig. S1 in [File S1](#pone.0081809.s001){ref-type="supplementary-material"}) which were mapped to the human reference genome (GRCh37/hg19) using TopHat. The uniquely mapped read localizations on the different chromosomes are shown in [Table 1](#pone-0081809-t001){ref-type="table"}. The aligned sequencing reads were assigned to the Homo_sapiens.GRCh37.71.gtf features as described above. Top 30 loci are shown in [Table 4](#pone-0081809-t004){ref-type="table"}. A full table of HTSeq counts is presented in Table S1 in [File S1](#pone.0081809.s001){ref-type="supplementary-material"}. The biological coefficient of variation as estimated by the edgeR software (<http://www.bioconductor.org/>) is shown in [figure 6](#pone-0081809-g006){ref-type="fig"}. There was a linear dependence between FPKM (Fragments Per Kilobase of transcript per Million mapped reads)-values in samples S1, S2 and S3. [Figure 7](#pone-0081809-g007){ref-type="fig"} shows a pair-wise comparison of S1 (male) and S2 (female) rendering a Pearson\'s correlation coefficient of 0.99. These results were confirmed by *de novo* assembly using the Trinity software ([Table 3b](#pone-0081809-t003){ref-type="table"}).

![Biological coefficient of variation of samples S1, S2 and S3 as estimated by TopHat/HTSeq/edgeR software.\
As expected the more highly expressed genes show much lower dispersion estimates than the mean value. "CPM" represents counts per million.](pone.0081809.g006){#pone-0081809-g006}

![Plot showing the magnitude of FPKM gene expression in rRNA-depleted total RNA in pair-wise comparisons between sample S1 and sample S2.\
Each dot represents a S1/S2 pair for a gene that had detectable expression in both samples. Pearson\'s correlation coefficient  = 0.99. (TopHat/Cufflinks/Cuffdiff/CummeRbund software).](pone.0081809.g007){#pone-0081809-g007}

10.1371/journal.pone.0081809.t004

###### TopHat/Cufflinks alignment of rRNA-depleted total RNA to genome (excluding ncrna).

![](pone.0081809.t004){#pone-0081809-t004-4}

  Ensembl id.          Gene               Locus            S1_FPKM[¶](#nt105){ref-type="table-fn"}   S2_FPKM[¶](#nt105){ref-type="table-fn"}   S3_FPKM[¶](#nt105){ref-type="table-fn"}   Rank
  ----------------- ----------- ------------------------- ----------------------------------------- ----------------------------------------- ----------------------------------------- ------
  ENSG00000205542     TMSB4X      X:12993226--12995346                      34973                                     28506                                     46120                     1
  ENSG00000163736      PPBP       4:74852754--74853914                      25489                                     23607                                     37832                     2
  ENSG00000198804     MT-CO1          MT:5903--7445                         23594                                     35045                                     27213                     MT
  ENSG00000198888     MT-ND1          MT:3306--4262                         17087                                     24640                                     18055                     MT
  ENSG00000198938     MT-CO3          MT:8365--9990                         16415                                     22715                                     15566                     MT
  ENSG00000198840     MT-ND3         MT:10058--10404                        15273                                     22805                                     14332                     MT
  ENSG00000198886     MT-ND4         MT:10469--12137                        14039                                     22467                                     9924                      MT
  ENSG00000198899     MT-ATP6         MT:8365--9990                         12643                                     15608                                     11442                     MT
  ENSG00000198727     MT-CYB         MT:14746--15887                        13017                                     15645                                     10847                     MT
  ENSG00000166710       B2M       15:45003674--45011075                     9394                                      11022                                     16484                     3
  ENSG00000212907     MT-ND4L        MT:10469--12137                        9394                                      18469                                     8991                      MT
  ENSG00000198786     MT-ND5         MT:12336--14148                        10900                                     16518                                     8191                      MT
  ENSG00000198712     MT-CO2          MT:7585--8269                         11460                                     15423                                     8156                      MT
  ENSG00000198763     MT-ND2          MT:4469--5511                         11304                                     16506                                     6650                      MT
  ENSG00000228253     MT-ATP8         MT:8365--9990                         12611                                     10792                                     9831                      MT
  ENSG00000163737       PF4       4:74844540--74848796                      5352                                      5933                                      9990                      4
  ENSG00000228474      OST4       2:27265231--27294641                      7326                                      4882                                      6268                      5
  ENSG00000180573    HIST1H2AC    6:26124372--26139344                      5539                                      6458                                      3635                      6
  ENSG00000150681      RGS18     1:192127586--192154945                     4310                                      6219                                      2841                      7
  ENSG00000075624      ACTB        7:5566781--5603415                       3375                                      2548                                      3199                      8
  ENSG00000167996      FTH1       11:61717292--61735132                     3044                                      2459                                      2413                      9
  ENSG00000198695     MT-ND6         MT:14148--14673                        2741                                      3190                                      1528                      MT
  ENSG00000127920      GNG11      7:93220884--93567791                      2369                                      1585                                      2850                      10
  ENSG00000168497      SDPR      2:192699027--193060435                     1809                                      2832                                      2040                      11
  ENSG00000154146      NRGN      11:124609809--124636392                    2807                                      1574                                      2154                      12
  ENSG00000101608     MYL12A       18:3247478--3261848                      2719                                      1959                                      1755                      13
  ENSG00000180596    HIST1H2BC    6:26115100--26124154                      2897                                      1822                                      1525                      14
  ENSG00000104904      OAZ1        19:2252251--2273487                      2003                                      1762                                      1954                      15
  ENSG00000163041      H3F3A     1:226249551--226259702                     1910                                      1233                                      1314                      16
  ENSG00000161570      CCL5       17:34195970--34212867                     1437                                      1760                                      1236                      17

Fragments Per Kilobase of transcript per Million mapped reads.

Further analyses to reveal differential expression (DE) were performed with Cufflinks and the bioinformatic tools HTseq and DESeq from Bioconductor (<http://www.bioconductor.org/>), which uses the R statistical programming language. [Figure 8](#pone-0081809-g008){ref-type="fig"} shows dispersion and log~2~ fold change when comparing the two male samples S1 and S3 with the female sample S2 using DESeq. Eighteen differentially expressed genes were identified between the two sexes at 10% false discovery rate (FDR) using DESeq ([Fig. 8](#pone-0081809-g008){ref-type="fig"}, red dots). Not all of these genes were located on the Y chromosome ([Table 5](#pone-0081809-t005){ref-type="table"}.).

![Graphs showing the dispersion and log~2~ fold change, respectively, when comparing the two male samples S1 and S3 with the female sample S2 using DESeq.\
The "dispersion" on the y-axis in the left-hand plot represents the square of the coefficient of biological variation, and the red "hockey-stick" line is a fitted curve through the estimates of the dispersion value for each gene. In the right-hand plot, the horizontal red line represents equal expression in male and female samples. Red dots represent differentially expressed genes at 10% FDR, and red triangles represent red dots that lie outside the graph (above or below). The identity of the differentially expressed genes and the corrresponding log~2~ fold changes can be found in [Table 5](#pone-0081809-t005){ref-type="table"} (columns 2 and 8, respectively).](pone.0081809.g008){#pone-0081809-g008}

10.1371/journal.pone.0081809.t005

###### Significantly differentially expressed genes in male and female platelets at 10% FDR as estimated by DESeq.

![](pone.0081809.t005){#pone-0081809-t005-5}

  Ensembl id.           gene              locus            baseMean   baseMeanA   baseMeanB   FC[\*](#nt106){ref-type="table-fn"}   log2 FC[\*](#nt106){ref-type="table-fn"}   pval[¶](#nt107){ref-type="table-fn"}   padj[§](#nt108){ref-type="table-fn"}
  ----------------- ------------ ------------------------ ---------- ----------- ----------- ------------------------------------- ------------------------------------------ -------------------------------------- --------------------------------------
  ENSG00000183878       UTY        Y:15360259--15592553     1511.7     2265.7        3.5                     0.002                                    −9.3                                   7.6E-27                                1.4E-22
  ENSG00000198692      EIF1AY      Y:22737611--22755040     618.0       925.3        3.5                     0.004                                    −8.0                                   4.4E-19                                4.0E-15
  ENSG00000210082     MT-RNR2         MT:1671--3229        160159.6    50966.7    378545.5                   7.427                                    2.9                                    3.5E-13                                2.2E-09
  ENSG00000116117      PARD3B     2:205410516--206484886    843.0       153.2      2222.5                    14.51                                    3.9                                    1.2E-12                                5.7E-09
  ENSG00000154620      TMSB4Y      Y:15815447--15817904     1407.2     2107.9        5.6                     0.003                                    −8.5                                   1.9E-12                                6.9E-09
  ENSG00000196565       HBG2       11:5274420--5667019      635.7       908.0       91.0                     0.100                                    −3.3                                   4.1E-10                                1.3E-06
  ENSG00000067048      DDX3Y       Y:15016019--15032390     884.4      1323.8        5.6                     0.004                                    −7.9                                   1.2E-09                                3.2E-06
  ENSG00000100362      PVALB      22:37196728--37215523     209.1       296.0       35.3                     0.119                                    −3.1                                   7.0E-09                                1.6E-05
  ENSG00000113658      SMAD5      5:135468534--135524435    1050.2      384.3      2382.0                    6.198                                    2.6                                    9.4E-09                                1.9E-05
  ENSG00000135426      TESPA1     12:55341802--55378530     321.0       59.3        844.6                    14.25                                    3.8                                    1.7E-08                                3.2E-05
  ENSG00000077984       CST7      20:24929866--24940564     140.5       208.9        3.5                     0.017                                    −5.9                                   2.6E-08                                4.4E-05
  ENSG00000118946      PCDH17     13:58205944--58303445      74.2       0.88        220.8                    251.4                                    8.0                                    6.0E-07                                9.2E-04
  ENSG00000248527     MTATP6P1       1:569076--569756       7122.7     3712.0      13944.1                   3.756                                    1.9                                    1.2E-06                                1.7E-03
  ENSG00000012817      KDM5D       Y:21865751--21906825     149.8       224.4       0.71                     0.003                                    −8.3                                   1.5E-06                                2.0E-03
  ENSG00000114374      USP9Y       Y:14813160--14972764     142.5       213.4       0.71                     0.003                                    −8.2                                   2.4E-06                                2.9E-03
  ENSG00000185736      ADARB2      10:1228073--1779670       79.2       118.8       0.00                     0.000                                    -Inf                                   1.53E-05                               1.7E-02
  ENSG00000229308    AC010084.1     Y:3904538--3968361      340.5      492.35       36.7                     0.075                                   −3.75                                   1.47E-05                               1.7E-02
  ENSG00000240356     RPL23AP7    2:114368079--114384667    6531.0     8750.85     2091.0                    0.239                                   −2.07                                   1.62E-05                               1.7E-02

\*Fold change;

P-value;

Adjusted P-value.

Differential expression at the gene level in polyA + mRNA vs total RNA {#s2c}
----------------------------------------------------------------------

Gene expression levels in total RNA samples are conventionally measured as RPKM (Reads Per Kilobase of transcript per Million mapped reads) or FPKM values assuming a rectangular distribution of reads covering the transcript coordinates, i.e. these measures are proportional to the number of reads divided by transcript lengths. The distribution of reads covering the transcript coordinates using oligo(dT) isolated mRNA is very different as it fits an exponential decay function from the 3′-end polyA site towards the 5′-end. ([Fig. 3](#pone-0081809-g003){ref-type="fig"} and [Fig. 4](#pone-0081809-g004){ref-type="fig"}). This makes RPKM and FPKM estimates less appropriate for comparison of gene expression levels in polyA + mRNA. Consequently, both transcript lengths and library preparation method ought to be taken into account. Otherwise, false differences will emerge. Adjusted bedcoverage data for the most abundant transcript of each gene is presented in Table S3 in [File S1](#pone.0081809.s001){ref-type="supplementary-material"} where columns S0, S1, S2, and S3 represent raw counts and columns S0_adj, and S1_adj to S3_adj represent Normalized Read Counts (NRC) and normalized FPKM figures, respectively (see [Table 3a](#pone-0081809-t003){ref-type="table"} for definition of NRC used in this context). [Table 3a](#pone-0081809-t003){ref-type="table"} demonstrates the fallaciousness of FPKM-values if used on poly(dT) selected transcripts. [Figure 9](#pone-0081809-g009){ref-type="fig"} shows a heatmap of such normalized levels of expression for the 30 most highly expressed genes across the samples from the 4 different patients. Altogether circa 500 differentially expressed genes were identified at 10% FDR comparing mRNA vs. totRNA using DESeq ([Fig. 10](#pone-0081809-g010){ref-type="fig"}). A full table of mRNA vs. totRNA comparisons is provided in Table S4 in [File S1](#pone.0081809.s001){ref-type="supplementary-material"}. As expected, most of this "DE", which primarily should represent preparation method and mapping artefacts, was observed for non-coding transcripts, which were not present in the polyA+ mRNA preparation, and mitochondrial rRNA transcripts which were more abundant in the polyA+ mRNA sample ([Table 6](#pone-0081809-t006){ref-type="table"}). However, coding transcripts that lack a polyA-tail should also appear as differentially expressed.

![Heatmap showing normalized levels of expression for the 30 most highly expressed gene transcripts across mRNA and rRNA-depleted total RNA samples from the 4 different patients.\
Nearly all differences of intensity for a given gene are likely to represent preparation artefacts, i.e. due to the poly(dT) enrichment and rRNA-depletion, respectively. Sample names have a 'C' added to indicate that the intensities represent length- and method-adjusted counts (TopHat/bedtools/DESeq and "in-house" software).](pone.0081809.g009){#pone-0081809-g009}

![Histogram of p-values from the call to negative binomial test with DESeq comparing the length- and method-adjusted counts of polyA + mRNA sample S0 with the rRNA-depleted total RNA samples S1, S2 and S3.\
Most of the circa 500 remaining significant differences after length- and method-adjusted normalization presumably represent preparation artefacts, i.e. due to the poly(dT) enrichment and rRNA-depletion, respectively. However, protein coding transcripts lacking a polyA-tail should also appear as differentially expressed. Note that omission of the length- and method-adjusted normalization yields a couple of thousand "differentially expressed" genes (TopHat/bedtools/DESeq and "in-house" software).](pone.0081809.g010){#pone-0081809-g010}

10.1371/journal.pone.0081809.t006

###### Significant DE[φ](#nt109){ref-type="table-fn"} among the most abundant transcripts in polyA+ mRNA versus rRNA-depleted total RNA.

![](pone.0081809.t006){#pone-0081809-t006-6}

  Ensembl id.           gene               locus             baseMean   baseMeanA   baseMeanB   FC[\*](#nt110){ref-type="table-fn"}   log2 FC[\*](#nt110){ref-type="table-fn"}   pval[¶](#nt111){ref-type="table-fn"}   padj^§^
  ----------------- ------------ -------------------------- ---------- ----------- ----------- ------------------------------------- ------------------------------------------ -------------------------------------- ---------
  ENSG00000210082     MT-RNR2         MT:1671--3229∶1        16931163   66886248     279467                    0.004                                    −7.9                                   4.0E-23                  2.8E-20
  ENSG00000266422    RN7SL593P    14:50053298--50053594∶1    6392989        0        8523986                    Inf                                     Inf                                    5.7E-09                  3.1E-07
  ENSG00000258486      RN7SL1     14:50053297--50053596∶1    6329059        0        8438746                    Inf                                     Inf                                    5.8E-09                  3.1E-07
  ENSG00000211459     MT-RNR1          MT:648--1601∶1        6194782    24607232      57298                    0.002                                   −8.75                                   3.8E-27                  4.0E-24
  ENSG00000265150      RN7SL2     14:50329271--50329567∶−1   6165927        0        8221236                    Inf                                     Inf                                    3.2E-12                  4.1E-10
  ENSG00000198888      MT-ND1         MT:3307--4262∶1        1690338     5336127     475075                    0.089                                    −3.5                                   6.8E-06                  1.9E-04
  ENSG00000163737       PF4       4:74846794--74847841∶−1    1375290     3880989     540057                    0.139                                    −2.9                                   1.7E-04                  3.3E-03
  ENSG00000198763      MT-ND2         MT:4470--5511∶1        1269252     3375664     567114                    0.168                                    −2.6                                   5.4E-04                  8.8E-03
  ENSG00000198712      MT-CO2         MT:7586--8269∶1        1191008     3025844     579396                    0.191                                    −2.4                                   1.3E-03                  1.8E-02
  ENSG00000228474       OST4      2:27293340--27294641∶−1     896875     2240352     449050                     0.2                                     −2.3                                   1.7E-03                  2.3E-02
  ENSG00000198899     MT-ATP6         MT:8527--9207∶1         770469     2046623     345084                    0.169                                    −2.6                                   5.8E-04                  9.4E-03
  ENSG00000198886      MT-ND4        MT:10760--12137∶1        768789     2051607     341183                    0.166                                    −2.6                                   5.2E-04                  8.6E-03
  ENSG00000198938      MT-CO3         MT:9207--9990∶1         728578     1653616     420232                    0.254                                    −2.0                                   6.4E-03                  6.8E-02
  ENSG00000187514       PTMA      2:232571605--232578251∶1    634893     2086609     150988                    0.072                                    −3.8                                   1.5E-06                  5.0E-05
  ENSG00000198786      MT-ND5        MT:12337--14148∶1        605680     1589548     277724                    0.175                                    −2.5                                   7.2E-04                  1.1E-02
  ENSG00000263900    AC006483.1    7:5567734--5567817∶−1      506347        0        675129                     Inf                                     Inf                                    5.6E-27                  5.0E-24
  ENSG00000210195      MT-TT         MT:15888--15953∶1        466133      82374      594053                    7.21                                     2.9                                    1.1E-03                  1.6E-02
  ENSG00000210049      MT-TF           MT:577--647∶1          464726      42641      605420                    14.20                                    3.8                                    2.6E-05                  6.2E-04
  ENSG00000161570       CCL5      17:34198495--34207797∶-1    392953     1050080     173911                    0.166                                    −2.6                                   5.5E-04                  9.0E-03
  ENSG00000198695      MT-ND6        MT:14149--14673∶−1       390765     897940      221707                    0.247                                    −2.0                                   5.5E-03                  6.0E-02
  ENSG00000209082      MT-TL1         MT:3230--3304∶1         337949     774474      192441                    0.248                                    −2.0                                   5.9E-03                  6.4E-02
  ENSG00000140264      SERF2      15:44069285--44094787∶1     252646     889675       40303                    0.045                                    −4.5                                   2.8E-08                  1.3E-06
  ENSG00000156265     MAP3K7CL    21:30449792--30548210∶1     240370        0        320494                     Inf                                     Inf                                    1.4E-16                  3.8E-14
  ENSG00000210196      MT-TP         MT:15956--16023∶−1       238130      41112      303802                    7.39                                     2.9                                    9.9E-04                  1.5E-02
  ENSG00000087086       FTL       19:49468558--49470135∶1     167208     518399       50145                    0.097                                    −3.4                                   1.7E-05                  4.2E-04
  ENSG00000210077      MT-TV          MT:1602--1670∶1         136962     329425       72807                    0.221                                    −2.2                                   3.3E-03                  3.9E-02
  ENSG00000142669     SH3BGRL3     1:26605667--26608007∶1     136382     503776       13917                    0.028                                    −5.2                                   2.3E-10                  1.9E-08
  ENSG00000169756      LIMS1      2:109150857--109303702∶1    124932     283811       71972                    0.254                                    −2.0                                   7.1E-03                  7.4E-02
  ENSG00000101608      MYL12A      18:3247479--3256234∶1      122263      3261       161930                    49.66                                    5.6                                    2.5E-06                  7.9E-05
  ENSG00000248527     MTATP6P1       1:569076--569756∶1       122224     401658       29079                    0.072                                    −3.8                                   2.0E-06                  6.2E-05

Differential Expression;

\*Fold change;

P-value; §Adjusted P-value.

The platelet transcriptome {#s2d}
--------------------------

The platelet transcriptome data was then compared with RNASeq data from Illumina\'s Human BodyMap 2.0 project. The Illumina data, generated on HiSeq 2000 instruments, consists of 16 human tissue types, including adrenal, adipose, brain, breast, colon, heart, kidney, liver, lung, lymph, ovary, prostate, skeletal muscle, testes, thyroid, and white blood cells. The heatmap in [figure 11](#pone-0081809-g011){ref-type="fig"} summarizes expression for this data integrated with the platelet raw data counts obtained with the HTSeq-counts program. The dendrogram at the top clearly shows that the platelet expression profile is unique because the samples S0,S1,S2 and S3 forms a cluster of its own from root level. As expected, the polyA+ mRNA sample S0 profile shows some DE when compared with the rRNA-depleted total RNA samples S1, S2, and S3. Thus, the present data suggests that platelets may have a unique transcriptome profile characterized by a relative over-expression of many mitochondrially encoded genes. Apart from MT-RNR1, MT-RNR2 and MT-TF, mitochondrially encoded gene expression levels were rather similar in totRNA and mRNA preparations ([Fig. 12](#pone-0081809-g012){ref-type="fig"} and [Table 7](#pone-0081809-t007){ref-type="table"}).

![The platelet transcriptome data compared with RNASeq data from Illumina\'s Human BodyMap 2.0 project.\
The integrated platelet data from samples S0, S1, S2, and S3 represent counts obtained with TopHat, Ensembl annotations, and the HTSeq-counts program. The Illumina codes are as follows. ERS025098 adipose, ERS025092 adrenal, ERS025085 brain, ERS025088 breast, ERS025089 colon, ERS025082 heart, ERS025081 kidney, ERS025096 liver, ERS025099 lung, ERS025086 lymphnode, ERS025084 mixture, ERS025087 mixture, ERS025093 mixture, ERS025083 ovary, ERS025095 prostate, ERS025097 skeletal_muscle, ERS025094 testes, ERS025090 thyroid, ERS025091 white_blood_cell.](pone.0081809.g011){#pone-0081809-g011}

![Differential expression of mitochondrial (MT)-genes in total RNA vs mRNA preparations.\
The figure shows that apart from MT-RNR1, MT-RNR2 and MT-TF, mitochondrially encoded gene expression levels were rather similar in rRNA-depleted total RNA and polyA + mRNA preparations (TopHat/HTSeq/edgeR software). "FC" denotes fold change whereas "CPM" represents counts per million.](pone.0081809.g012){#pone-0081809-g012}

10.1371/journal.pone.0081809.t007

###### Read count table for mitochondrially encoded genes for samples S0, S1, S2 and S3.

![](pone.0081809.t007){#pone-0081809-t007-7}

  Ensembl id.          gene           locus          length      S0        S1        S2        S3
  ------------------ --------- -------------------- -------- ---------- --------- --------- ---------
  ENSG00000210049      MT-TF      MT:577--647∶1        71       4716      72194     45984     42484
  ENSG00000211459     MT-RNR1     MT:648--1601∶1      954     4626427     98775     54719     51139
  ENSG00000210077      MT-TV     MT:1602--1670∶1       69      36340      10399     6856      1215
  ENSG00000210082     MT-RNR2    MT:1671--3229∶1      1559    13296885   250572    1137529   153605
  ENSG00000209082     MT-TL1     MT:3230--3304∶1       75      86075      20917     13706     19721
  ENSG00000198888     MT-ND1     MT:3307--4262∶1      956     1003620    480131    557853    659073
  ENSG00000210100      MT-TI     MT:4263--4331∶1       69      19538      21026     11319     7338
  ENSG00000210107      MT-TQ     MT:4329--4400∶−1      72      26650      31551     37167     27844
  ENSG00000210112      MT-TM     MT:4402--4469∶1       68      53547      40780     53844     59771
  ENSG00000198763     MT-ND2     MT:4470--5511∶1      1042     643951    625223    928642    622441
  ENSG00000210117      MT-TW     MT:5512--5579∶1       68       7355      19999     8161      3780
  ENSG00000210127      MT-TA     MT:5587--5655∶−1      69       6825      13478     5840      3956
  ENSG00000210135      MT-TN     MT:5657--5729∶−1      73       8457      11923     4449      4815
  ENSG00000210140      MT-TC     MT:5761--5826∶−1      66      12786      7746      3790      3592
  ENSG00000210144      MT-TY     MT:5826--5891∶−1      66       8401      8967      4896      4065
  ENSG00000198804     MT-CO1     MT:5904--7445∶1      1542     414158    1257943   1669453   1633848
  ENSG00000210151     MT-TS1     MT:7446--7514∶−1      69      32507      12569     11010     9894
  ENSG00000210154      MT-TD     MT:7518--7585∶1       68       7787      7045      6504      4022
  ENSG00000198712     MT-CO2     MT:7586--8269∶1      684      529645    397862    485662    598293
  ENSG00000210156      MT-TK     MT:8295--8364∶1       70      16629      14388     13232     15576
  ENSG00000228253     MT-ATP8    MT:8366--8572∶1      207      61948      66353     72109     65706
  ENSG00000198899     MT-ATP6    MT:8527--9207∶1      681      357851    277472    294047    304636
  ENSG00000198938     MT-CO3     MT:9207--9990∶1      784      298920    387019    407105    435081
  ENSG00000210164      MT-TG     MT:9991--10058∶1      68       6289      11269     13275     11525
  ENSG00000198840     MT-ND3    MT:10059--10404∶1     346      86378      92634    121847    146128
  ENSG00000210174      MT-TR    MT:10405--10469∶1      65       8430      11341     17249     19014
  ENSG00000212907     MT-ND4L   MT:10470--10766∶1     297      111257    118428    203231    207225
  ENSG00000198886     MT-ND4    MT:10760--12137∶1     1378     404373    502675    664748    575461
  ENSG00000210176      MT-TH    MT:12138--12206∶1      69      10272      14951     7898      7056
  ENSG00000210184     MT-TS2    MT:12207--12265∶1      59       8641      6673      7713      13231
  ENSG00000210191     MT-TL2    MT:12266--12336∶1      71       8013      8112      9209      12015
  ENSG00000198786     MT-ND5    MT:12337--14148∶1     1812     318124    585691    707224    571473
  ENSG00000198695     MT-ND6    MT:14149--14673∶−1    525      146565    167234    175374     85557
  ENSG00000210194      MT-TE    MT:14674--14742∶−1     69       7417      14089     15081     13333
  ENSG00000198727     MT-CYB    MT:14747--15887∶1     1141     220495    447899    453336    452116
  ENSG00000210195      MT-TT    MT:15888--15953∶1      66       9053      52084     45617     48793
  ENSG00000210196      MT-TP     MT:15956--16023       68       4530      31223     21717     24467
  Sum                                                         22910855   6198635   8297396   6919289
  Sum without rRNA                                            4987543    5849288   7105148   6714545

As shown in [Figure 11](#pone-0081809-g011){ref-type="fig"} transcripts from some nuclear genes, particularly TMSB4X, were also more abundant in human platelets as compared to the other cells and tissues. TMSB4X plays a role in regulation of actin polymerization, and is involved in cell proliferation, migration, and differentiation [@pone.0081809-Kaur1]. Furthermore, several genes involved in signal transduction, including chemokines were also abundantly expressed, particularly *PPBP*. The protein encoded by this gene is a platelet-derived growth factor that belongs to the CXC chemokine family, and is a potent chemoattractant for neutrophils [@pone.0081809-Schenk1]. *B2M* (beta-2-microglogulin gene) encodes a serum protein found in association with the major histocompatibility complex (MHC) class I heavy chain on the surface of nearly all nucleated cells [@pone.0081809-Hee1]. The PF4 chemokine is released from the alpha granules of activated platelets in the form of a homotetramer, which has high affinity for heparin and is involved in platelet aggregation [@pone.0081809-Farbiszewski1]. ACTB is a major constituent of the contractile apparatus and one of the two nonmuscle cytoskeletal actins [@pone.0081809-Perrin1].

The full table of platelet RNASeq data integrated in Illumina\'s Human BodyMap 2.0 project is available in Table S5 in [File S1](#pone.0081809.s001){ref-type="supplementary-material"}.

Functional classification of platelet coding transcripts {#s2e}
--------------------------------------------------------

We used the web-based PANTHER software (<http://www.pantherdb.org/about.jsp>) [@pone.0081809-Thomas1] to classify proteins coded by the top 50 platelet genes using either polyA+ or rRNA-depleted total RNA transcripts mapped against the reference genome. The corresponding genes were grouped into clusters representing gene ontology (GO) categories of molecular functions ([Fig. 13](#pone-0081809-g013){ref-type="fig"}). A major finding with this analysis was that the molecular function groups of the top 50 platelet genes for polyA+ enriched RNA ([Fig. 13A](#pone-0081809-g013){ref-type="fig"}) correlated remarkably well with those of rRNA-depleted total RNA ([Fig. 13B](#pone-0081809-g013){ref-type="fig"}) despite the two distinct approaches and different donors. Among the molecular function GO groups shown in [Figure 13](#pone-0081809-g013){ref-type="fig"}, the category b*inding* (GO:0005488) seems to dominate in each top 50 list. As shown in [Table 8](#pone-0081809-t008){ref-type="table"} most of the genes in this category belong to the *protein binding* subgroup, a class that is expected to play a prominent role in platelet functions. Another noticeable category is the *structural molecule activity* group. This category entails structural constituents of the cytoskeleton, and critical functions concerning cell motility and organization.

![Classification of the proteins coded by the most abundant (top 50) coding transcripts of human platelets.\
Bars represent molecular function categories generated by the PANTHER gene ontology classification web-based tool. A) Sequencing was performed on polyA+ enriched RNA, whereas in B) rRNA-depleted total RNA was analyzed.](pone.0081809.g013){#pone-0081809-g013}

10.1371/journal.pone.0081809.t008

###### The function of the proteins coded by top 50 platelet genes, as provided by PANTHER gene ontology classification web-based tool.

![](pone.0081809.t008){#pone-0081809-t008-8}

  Nr.        Molecular function category (GO term)                     Sub category (GO term)                  Number of genes
  ----- ----------------------------------------------- ----------------------------------------------------- -----------------
  1            Antioxidant activity (GO:0016209)                n.a.[\*](#nt112){ref-type="table-fn"}                --
  2                  Binding (GO:0005488)                         Calcium ion binding (GO:0005509)                    2
                                                                  Nucleic acid binding (GO:0003676)                   6
                                                                    Protein binding (GO:0005515)                     14
  3             Catalytic activity (GO:0003824)                    Hydrolase activity (GO:0016787)                    2
                                                                    Ligase activity (GO:0016874)                      2
                                                                Oxidoreductase activity (GO:0016491)                  1
                                                                  Transferase activity (GO:0016740)                   1
  4         Enzyme regulator activity (GO:0030234)             Enzyme activator activity (GO:0008047)                 1
                                                               Enzyme inhibitor activity (GO:0004857)                 2
                                                               Kinase regulator activity (GO:0019207)                 1
                                                            Small GTPase regulator activity (GO:0005083)              4
  5             Receptor activity (GO:0004872)                  n.a.[\*](#nt112){ref-type="table-fn"}                --
  6        Structural molecule activity (GO:0005198)     Structural constituent of cytoskeleton (GO:0005200)          9
  7      Transcription regulator activity (GO:0030528)      Transcription cofactor activity (GO:0003712)              1
                                                             Transcription factor activity (GO:0003700)               4
  8            Transporter activity (GO:0005215)                n.a.[\*](#nt112){ref-type="table-fn"}                --

\*Not available because of too few genes.

Discussion {#s3}
==========

In the present study we have compared results of RNA-Seq mapping of polyA+ transcripts in purified blood platelets with those obtained with rRNA-depleted total RNA from healthy blood donors against the set of chromosomes of the Human Feb. 2009 (GRCh37/hg19) assembly (<http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/>). Based on four individuals, the present data show an apparently unique transcriptome profile as compared with other tissues of the Illumina bodymap 2.0 project.

In a typical RNA-Seq experiment, reads are sampled from RNA extracts and either mapped back to a reference genome or used for *de novo* assembly. Alignment and assembly of short or inaccurate reads poses a problem, which we have avoided by using 100 bp high quality Illumina reads. How closely the cDNA sequencing reflects the original RNA population is supposedly mainly determined in the library preparation step. As expected, our mapping of polyA+ reads showed a substantial bias for the 3′-end of gene transcripts due to the selection of mRNA using oligo-dT during the RNA extraction procedure and the following cDNA preparation step [@pone.0081809-Cheung1]. This 3′-UTR bias follows an exponential decay function. After length correction of coverage figures using that function for mRNA and FPKM-values for total RNA, we obtained a reasonably good agreement between quantitative estimates from mapping of polyA+ mRNA and rRNA-depleted total RNA reads to the human genome GRCh37/hg19. It is a notoriously difficult problem to assign reads to a particular isoform if there are many transcript variants with overlaps between them. Very high coverage figures are needed for satisfactory results. This is one of the reasons why RNA-Seq with low coverage has many of the same limitations as other RNA expression analysis pipelines.

Obviously, mapping of reads against the human genome and also mapping against the human exome both rely on the accuracy of gene and transcript annotations. In order to fully characterize the platelet transcriptome without reference to previous results, including the possibility to detect and fully characterize novel transcripts, we also performed a *de novo* assembly of transcripts using Trinity RNA-Seq software (<http://trinityrnaseq.sourceforge.net/>). This software will extract full-length transcripts for alternatively spliced isoforms based on the generation and analysis of de Bruijn graphs. RSEM software with the bowtie aligner (<http://bowtie-bio.sourceforge.net/>) was used for mapping the RNA-Seq reads back to the reported transcripts for abundance estimation. Identification of the transcripts was achieved by Blat and BLAST searches using the UCSC Browser and the NCBI Genome databases, respectively. These data fully supported our results obtained by mapping the reads to the human genome and exome, respectively, using gtf.guided assembly. However, even if transcript abundance figures agreed only the most abundant transcripts could be reliably reconstructed by the *de novo* assembly approach; presumably due to insufficient amounts of reads that were available.

When we started this study there was no published RNA-Seq data on platelet gene expression although microarray based as well as SAGE and real-time PCR methods have been used in the past. However, two studies using RNA-Seq by NGS were published during the progress of this study. One of these studies was reported by Rowley et al. who used polyA+ enriched RNA to characterize the transcriptomes of human and mouse platelets [@pone.0081809-Rowley1]. In contrast, Bray et al. utilized rRNA-depleted total RNA and found that their data correlated with those of previously reported microarray transcriptome data at least for the well-expressed mRNAs [@pone.0081809-Bray1]. Both studies used relatively short sequence reads (≤50 bp for Rowley et al. and ≤40 bp for Bray et al.). The present study employed different strategies for library preparation in addition to the longer (100 bp) read length used for mapping. It is thus expected that there might exist some discrepancies between the current and the previously reported platelet transcript data. A notable difference is the "missed" NGRN transcripts (i.e. an at least tenfold lower amount) in our study when compared to the data of Rowley et al., which possibly could be due to differences of the sample preparation method. However, it should also be kept in mind that when adopting available NGS software for the RNA-seq analyses even small changes in parameter settings can produce a remarkably different result. We used settings of the Bowtie program allowing only 2 mismatches when aligning 100 bp reads to the reference sequence. Context sequencing errors (CSE) that are supposedly specific for the sequencing platform could obviously affect the read counts under such circumstances but a \>10-fold reduction seems unlikely because reads from the reverse strand in the mRNA sample S0 should not have been affected to the same extent. One could also speculate whether RNA editing might influence the mapping of our platelet RNA transcripts. Adenosine to inosine (A\>I) RNA editing occurs widely across the human transcriptome in certain tissues, especially in the brain [@pone.0081809-Peng1]. Although there is no data available regarding RNA editing in platelets, we cannot exclude that possibility. However, RNA editing of protein-coding regions appears to be relatively rare events, and may thus have had limited impact on the mapping of cDNA from platelet transcripts.

The relative frequency of reads mapping uniquely to genes involved in platelet function and our molecular function protein classification by PANTHER software is consistent with but does not prove the notion that at least some mRNAs in platelets are not merely remnants from the megakaryocytes without function, but rather reflect an important role of mRNA in the physiological function of platelets. In this regard, it is not surprising that many of the proteins coded by top 50 platelet genes represent key platelet functions such as structural constituent of cytoskeleton, protein binding, calcium binding and signal transduction. On the other hand transcripts of some genes encoding prominent platelet receptors were missing or present with few sequence reads, suggesting that no further synthesis of such proteins is needed after platelet formation in the bone marrow. We also searched for transcript signal for tissue factor (TF) since this protein\'s eventual presence and function in platelets has been debated for years. However, we could not detect any transcripts encoding TF. Interestingly, Schwertz et al. reported that resting platelets contain TF pre-mRNA that, upon activation, is spliced into mature mRNA, indicating that only activated platelets express mature TF mRNA transcripts [@pone.0081809-Schwertz1].

Simultaneously, we have confirmed the dominant frequency of mitochondrially expressed genes comprising the platelet mRNA pool. Specifically in our polyA+ mRNA study, 22,416,906 out of 35,322,009 uniquely mapped reads represent MT-transcripts, apparently related to persistent MT-transcription in the absence of nuclear-derived transcription. This is not unexpected as platelets are metabolically adapted to rapidly expend large amounts of energy required for aggregation, granule release, and clot retraction.

Conclusions {#s4}
===========

This study demonstrates that human platelets carry a unique signature of well-defined and highly abundant coding transcripts that are expressed at similar levels among individuals. However, the *in vivo* functional significance of nuclearly encoded platelet mRNAs remains to be shown. Future studies need to focus on establishing the biological and biochemical functions of the identified genes in the physiological and pathological regulation of platelets. The desired end point would be to define a platelet mRNA profile that is directly associated with athero-thrombotic disease, which could eventually lead to the identification of novel targets for anti-thrombotic agents.

Methods {#s5}
=======

Ethical statement {#s5a}
-----------------

The Regional Ethical Review Board in Linköping (EPN; <http://www.epn.se/start/startpage.aspx>; Linköping, Sweden) granted an ethical permission for this study (permission number M74-09). Informed written consent was obtained from all participants involved in this study.

Platelet preparation {#s5b}
--------------------

Non-irradiated apheresis platelets were collected from healthy blood donors. Platelets were collected by COBE Spectra system (Gambro BCT) as previously described [@pone.0081809-Tynngard1] and were used on the same collection day. Residual leukocytes were depleted with anti-CD45 conjugated Dynabeads, according to the manufacturer\'s recommendations (Pan Leukocyte; Invitrogen, Carlsbad, CA). The platelet suspension, with a volume of 30 mL and a platelet count of 1.4×10^9^ cells/mL, was centrifuged at 800 g for 8 min and the supernatant was discarded. The platelet pellet was processed for leukocyte depletion, as recommended by the supplier of the Pan Leukocyte reagent (Invitrogen, Carlsbad, CA). Since leukocytes possess magnitudes of order more mRNA than platelets, the purification of platelets is a pivotal step. The leukocyte removal was performed at room temperature. Approximately 70--75% of the original platelets were recovered after the leukocyte depletion. To investigate the level of leukocyte contamination, we determined the level of CD45 (*PTPRC*) transcript in multiple platelet preparations (n = 6) by qPCR using TaqMan Gene Expression Assay for this gene according to the recommendations of the supplier (Assay ID: Hs00894713_m1; Applied Bioystems, Carlsbad, CA, USA).

RNA extraction and cDNA synthesis {#s5c}
---------------------------------

The different strategies used for RNA-extraction, library preparation, sequencing and mapping are graphically depicted in [Figure 1](#pone-0081809-g001){ref-type="fig"}. For isolation of total RNA, we employed the miRVana RNA Extraction Kit as recommended by the supplier (Life Technologies). Isolation of polyA+ mRNA and synthesis of cDNA were performed by the method described by Rox et al. [@pone.0081809-Perrin1], with the exception that we used Smarter PCR cDNA Synthesis kit for the cDNA synthesis (Clontech, Mountain View, CA, USA). Briefly, the leukocyte-depleted platelet suspension was centrifuged at 1000 g for 10 min and the supernatant was discarded. PolyA+ mRNA was isolated from the platelet cell pellet by using Dynabeads Oligo(dT)~25~ according to the instruction of the manufacturer (Invitrogen, Carlsbad, CA, USA). To synthesize the first-strand cDNA, 3.5 µL of polyA+ mRNA was combined with 1 µL of 3′-Smart CDS primer II A (12 µM). After mixing the tube, the sample was incubated at 72 C for 3 min and then at 42 C for 2 min. This was followed by the addition of a master mix containing 2 µL of 5 First-Strand Buffer, 0.25 µL DTT (100 mM), 1 µL dNTP mix (10 mM), 1 µL SMARTer IIA oligonucleotide (12 µM), 0.25 µL RNase inhibitor, and 1 µL of SMARTScribe Reverse Transcriptase (100 U). The reverse transcription was run by incubating the tube at 42 C for 1 h before the reaction was terminated at 70 C for 10 min. The sample was then diluted with 90 µL of TE-buffer (10 nM Tris, 1 nM EDTA, pH 8.0). To run Long-Distance PCR, 10 µL of the diluted and reverse-transcribed platelet cDNA was mixed with 10 µL 10 Advantage 2 PCR buffer, 2 µL 50 dNTP mix (10 mM), 2 µL 5′PCR primer IIA (12 µM), 2 µL 50 Advantage 2 polymerase mix, and 74 µL of deionized water to a final volume of 100 µL. The sample was then incubated in a thermal cycler running a PCR program containing 95 C for 1 min, and then 20 cycles of 95 C for 15 s, 65 C for 30 s, and 68 C for 3 min. The synthesized platelet cDNA was purified with QIAquick PCR purification kit according to the manufacturer\'s instructions (Qiagen, Hilden, Germany), and the amount of cDNA was estimated on a Nanodrop spectrophotometer (ND1000; Saveen & Werner, Limhamn, Sweden).

Illumina HiSeq2000 sequencing {#s5d}
-----------------------------

The cDNA obtained from the platelet polyA+ mRNA sample was shotgun sequenced (1×100 bp single read module) with the Illumina HiSeq 2000® instrument (Illumina, San Diego, CA, USA) by using a customer sequencing service (Eurofins MWG Operon, Ebersberg, Germany) which also included nebulization and end repair of cDNA, ligation of adaptors, gel purification, PCR amplification and library purification. The number of raw sequencing reads was 65,111,491. Filtering to remove bad quality bases and reads resulted in 58,155,680 reads (89.3%). These sequences were then mapped against the set of chromosomes of the Human Feb. 2009 (GRCh37/hg19) assembly. Initially, the mapping was conducted using the software TopHat 1.2.0 (<http://tophat.cbcb.umd.edu>). The post-processing of the mapping results was conducted using SamTools 0.1.12 a (<http://samtools.sourceforge.net>) and custom made Ruby 1.8.7 software. Bowtie <http://bowtie-bio.sourceforge.net/> and bwa <http://bio-bwa.sourceforge.net/> were used for aligning to de novo assembled transcripts and RefSeq mRNA respectively.

RNA samples from three platelet donors were prepared for total RNA sequencing. For these samples, ribosomal RNA was depleted with Ribo-Zero (Epicentre, Madison, WI, USA) and strand specific barcoded RNA-sequencing libraries were prepared using ScriptSeq v2 (Epicentre) according to manufacturers instructions. The barcoded libraries were run on a single lane paired end 100 bp on a HiSeq2000® (Illumina, San Diego, CA, USA), which resulted in 153 million pass filter read pairs. QC data can be found in Figure S1 in [File S1](#pone.0081809.s001){ref-type="supplementary-material"}. The TopHat2 software was used with the bowtie aligner.

Submission of the sequencing data to public repository {#s5e}
------------------------------------------------------

The complete sequencing data is publicly available at The European Nucleotide Archive (<http://www.ebi.ac.uk/ena/>) under the accession numbers E-MTAB-715 (polyA+ transcripts) and E-MTAB-1846 (total RNA transcripts). Both accession numbers are cross-referenced to one another.

Assembly of reads and bioinformatics {#s5f}
------------------------------------

*de novo* assembly of transcripts was performed using the Trinity RNA-Seq software (<http://trinityrnaseq.sourceforge.net>).

Supporting Information {#s6}
======================
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**Contents**: Table S1: HTSeq raw counts per gene in samples S0, S1, S2, and S3. Table S2: Mapping of S0 (poly(dT) selected transcripts) against RefSeq mRNA. Table S3: Length and method (NRC/FPKM) adjusted counts per gene as represented by the most abundant transcript in samples S0, S1, S2, and S3. Table S4: Differential expression of genes in polyA+ mRNA (A) versus rRNA-depleted total RNA (B). Table S5: The S0, S1, S2 and S3 RNA-Seq data integrated with Illumina\'s Human BodyMap 2.0 project raw data. Figure S1: QC report.
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